Lindbrook Capital, LLC Leap Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$2.08 - $3.65 $20,800 - $36,500	-10,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$1.35 - $4.01 $12,150 - $36,090	9,000 Added 900.0%	10,000 $40,000
Q1 2021 Apr 28, 2021	BUY	$1.82 - $3.01 $1,820 - $3,010	1,000 New	1,000 $2,000
Q3 2020 Nov 03, 2020	SELL	$1.68 - $2.17 $5,040 - $6,510	-3,000 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$1.39 - $2.84 $4,170 - $8,520	3,000 New	3,000 $6,000
Q3 2019 Oct 31, 2019	SELL	$1.17 - $2.36 $1,755 - $3,540	-1,500 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$1.36 - $2.07 $680 - $1,035	500 Added 50.0%	1,500 $2,000
Q1 2019 Apr 23, 2019	BUY	$1.39 - $3.07 $1,390 - $3,070	1,000 New	1,000 $1,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.